We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
1126
Amneal Pharmaceuticals
AMRX
$5.79B
– –
-66,512
Closed -$942K
AMRC icon
1127
Ameresco
AMRC
$1.36B
– –
-24,445
Closed -$396K
ANET icon
1128
Arista Networks
ANET
$238B
– –
-121,536
Closed -$2.39M
ANIX icon
1129
Anixa Biosciences
ANIX
$116M
– –
-3
Closed –
AON icon
1130
Aon
AON
$76B
– –
-12,598
Closed -$2.15M
APAM icon
1131
Artisan Partners
APAM
$3.02B
– –
-13,795
Closed -$348K
APLE icon
1132
Apple Hospitality REIT
APLE
$3.82B
– –
-153
Closed -$2K
APPN icon
1133
Appian
APPN
$2.48B
– –
-39,231
Closed -$1.35M
APTV icon
1134
Aptiv
APTV
$10.3B
– –
-2,300
Closed -$183K
AQN icon
1135
Algonquin Power & Utilities
AQN
$4.42B
– –
-222,628
Closed -$2.5M
AR icon
1136
Antero Resources
AR
$10.7B
– –
-351,806
Closed -$3.11M
ARES icon
1137
Ares Management
ARES
$30.9B
– –
-7,537
Closed -$175K
ARI
1138
Apollo Commercial Real Estate
ARI
$885M
– –
-1,400
Closed -$25K
ARTNA icon
1139
Artesian Resources
ARTNA
$358M
– –
-1,083
Closed -$40K
ARVN icon
1140
Arvinas
ARVN
$572M
– –
-123,732
Closed -$1.83M
ASMB icon
1141
Assembly Biosciences
ASMB
$529M
– –
-369
Closed -$87K
ASR icon
1142
Grupo Aeroportuario del Sureste
ASR
$8.3B
– –
-624
Closed -$101K
ASX icon
1143
ASE Group
ASX
$82.2B
– –
-14,264
Closed -$61K
ASYS icon
1144
Amtech Systems
ASYS
$272M
– –
-60
Closed –
ATEN icon
1145
A10 Networks
ATEN
$1.95B
– –
-39,139
Closed -$277K
ATNI icon
1146
ATN International
ATNI
$492M
– –
-972
Closed -$55K
ATRA icon
1147
Atara Biotherapeutics
ATRA
$76.1M
– –
-1,973
Closed -$1.96M
AU icon
1148
AngloGold Ashanti
AU
$48.7B
– –
-11,100
Closed -$145K
AUB icon
1149
Atlantic Union Bankshares
AUB
$5.97B
– –
-6,060
Closed -$196K
AVA icon
1150
Avista
AVA
$3.24B
– –
-1,094
Closed -$44K
44 45
46
47 48

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.